Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
CEO Vounatsos, Aduhelm Commercial Team To Exit As Biogen Shifts Focus
More Jobs, Cost Cuts Bring Year’s Total To $1bn
May 03 2022
•
By
Mandy Jackson
Biogen is shutting down nearly all Aduhelm commercial operations • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Earnings
More from Business